Adverse effect · Semaglutide

How common is GI side effects with Semaglutide?

A
Grade A — established in humansAll trials · effect size: large · adverse
Short answerEstablished in humans. All trials point the same way: a large effect. Nausea, vomiting and constipation are the most common reasons people stop. Well quantified.

What the studies show

Nausea, vomiting and constipation are the most common reasons people stop. Well quantified.

Several well-run randomised trials in people, pointing the same way. You can plan around this. It still says nothing about whether the effect is worth the side effects for you.

  1. 1
    Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1).N Engl J Med, 2021;384:989–10021,961 adults; −14.9% vs −2.4% at 68 weeks.
  2. 2
    Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT).N Engl J Med, 2023;389:2221–223217,604 participants; hazard ratio 0.80 for MACE.

In context

Semaglutide is a once-weekly GLP-1 receptor agonist approved for type 2 diabetes and, at a higher dose, for weight management. In large randomised trials it produces roughly 15% average weight loss over 68 weeks and reduces major cardiovascular events in people with existing heart disease. Gastrointestinal side effects are common and are the main reason people stop. It is a prescription medicine; products sold outside that channel are unlicensed copies.

Semaglutide is approved (rx). Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Semaglutide proven to cause GI side effects?
Yes, as far as human trials can show it: All trials. LYO grades this outcome A.
What studies are behind the grade?
Nausea, vomiting and constipation are the most common reasons people stop. Well quantified.
Is Semaglutide approved for this?
Semaglutide is an approved medicine (Approved (Rx)); whether this particular outcome is a licensed indication is stated on the compound page's regulation section.

Other outcomes for Semaglutide

Reviewed 1 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →